April 2017
Oncology
Peer Reviewed | Web-Exclusive

Sign in to continue reading this article

Not registered? Create an account for free to read full articles on www.cliniciansbrief.com.

To access full articles on www.cliniciansbrief.com, please sign in below.

Busy? Sign in Faster. Sign into www.cliniciansbrief.com with your social media account.
...  Questions
Multiple Choice Questions
Questions  .../...
Score  .../...

Quiz: Mast Cell Tumors

Quiz: Mast Cell Tumors

Final score
... of ...
Take this quiz by answering the following multiple choice questions. Start Quiz
Quiz: Mast Cell Tumors
Previous Next Submit Finish
 
Related Articles
References and author information Show
References
  1. Allison RW, Velguth KE. Appearance of granulated cells in blood films stained by automated aqueous versus methanolic Romanowsky methods. Vet Clin Pathol. 2010;39(1):99-104.
  2. Griffiths GL, Lumsden JH, Valli VE. Fine needle aspiration cytology and histologic correlation in canine tumors. Vet Clin Pathol. 1984;13(1):13-17.
  3. Friedrichs KR, Young KM. Diagnostic cytopathology in clinical oncology. In: Withrow SJ, Vail DM, Page R, eds. Withrow and MacEwen’s Small Animal Clinical Oncology. 5th ed. Philadelphia, PA: Elsevier Saunders; 2013:127.
  4. Jackson DE, Selting KA, Spoor MS, Henry CJ, Wiedmeyer CE. Evaluation of fixation time using Diff-Quik for staining of canine mast cell tumor aspirates. Vet Clin Pathol. 2013;42(1):99-102.
  5. Mullins MN, Dernell WS, Withrow SJ, Ehrhart EJ, Thamm DH, Lana SE. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004). J Am Vet Med Assoc. 2006;228(1):91-95.
  6. Peters JA. Canine mastocytoma: excess risk as related to ancestry. J Natl Cancer Inst. 1969:42(3):435-443.
  7. Fulcher RP, Ludwig LL, Bergman PJ, Newman SJ, Simpson AM, Patnaik AK. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs. J Am Vet Med Assoc. 2006;228(2):210-215.
  8. Kry KL, Boston SE. Additional local therapy with primary re-excision or radiation therapy improves survival and local control after incomplete or close surgical excision of mast cell tumors in dogs. Vet Surg. 2014;43(2):182-189.
  9. Perry JA, Culp WTN, Dailey DD, Eickhoff JC, Kamstock DA, Thamm DH. Diagnostic accuracy of pre-treatment biopsy for grading soft tissue sarcomas in dogs. Vet Comp Oncol. 2014;12(2):106-113.  
  10. Miller RL, Van Lelyveld S, Warland J, Dobson JM, Foale RD. A retrospective review of treatment and response of high-risk mast cell tumours in dogs. Vet Comp Oncol. 2014;doi: 10.1111/vco.12116 [Epub ahead of print].
  11. Simpson AM, Ludwig LL, Newman SJ, Bergman PJ, Hottinger HA, Patnaik AK. Evaluation of surgical margins required for complete excision of cutaneous mast cell tumors in dogs. J Am Vet Med Assoc. 2004;224(2):236-240.
  12. Stanclift RM, Gilson SD. Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs. J Am Vet Med Assoc. 2008;232(1):53-62.
  13. Fox LE, Rosenthal RC, Twedt DC, Dubielzig RR, MacEwen EG, Grauer GF. Plasma histamine and gastrin concentrations in 17 dogs with mast cell tumors. J Vet Intern Med. 1990;4(5):242-246.
  14. Ishiguro T, Kadosawa T, Takagi S, et al. Relationship of disease progression and plasma histamine concentrations in 11 dogs with mast cell tumors. J Vet Intern Med. 2003;17(2):194-198.
  15. Worley DR. Incorporation of sentinel lymph node mapping in dogs with mast cell tumours: 20 consecutive procedures. Vet Comp Oncol. 2014;12(3):215-226.
  16. Suami H, Yamashita S, Soto-Miranda MA, Chang DW. Lymphatic territories (lymphosomes) in a canine: an animal model for investigation of postoperative lymphatic alterations. PLoS One. 2013;8(7):e69222.
  17. Book AP, Fidel J, Wills T, Bryan J, Sellon R, Mattoon J. Correlation of ultrasound findings, liver and spleen cytology, and prognosis in the clinical staging of high metastatic risk canine mast cell tumors. Vet Radiol Ultrasound. 2011;52(5):548-554.
  18. Gieger TL, Théon AP, Werner JA, McEntee MC, Rassnick KM, DeCock HE. Biologic behavior and prognostic factors for mast cell tumors of the canine muzzle: 24 cases (1990-2001). J Vet Intern Med. 2003;17(5):687-692.
  19. Baginski H1, Davis G, Bastian RP. The prognostic value of lymph node metastasis with grade 2 MCTs in dogs: 55 cases (2001-2010). J Am Anim Hosp Assoc. 2014;50(2):89-95.
  20. Weishaar KM, Thamm Dh, Worley DR, Kamstock DA. Correlation of nodal mast cells with clinical outcome in dogs with mast cell tumour and a proposed classification system for the evaluation of node metastasis. J Comp Pathol. 2014;151(4):329-338.
  21. Stefanello D, Baracco P, Sabattini S, et al. Comparison of 2- and 3-category histologic grading systems for predicting the presence of metastasis at the time of initial evaluation in dogs with cutaneous mast cell tumors: 386 cases (2009-2014). J Am Vet Med Assoc. 2015;246(7):765-769.
  22. McManus PM. Frequency and severity of mastocytemia in dogs with and without mast cell tumors: 120 cases (1995-1997). J Am Vet Med Assoc. 1999;215(3):355-357.
  23. Lejeune A, Skorupski K, Frazier, et al. Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012). Vet Comp Oncol. 2015;13(3):267-280.
  24. Bostock DE. Neoplasms of the skin and subcutaneous tissues in dogs and cats. Br Vet J. 1986;142(1):1-19.
  25. Seguin B, Besancon ME, McCallan JL, et al. Recurrence rate, clinical outcome, and cellular proliferation indices as prognostic indicators after incomplete surgical excision of cutaneous grade II mast cell tumors: 28 dogs (1994-2002). J Vet Intern Med. 2006;20(4):933-940. 
Author

Jennifer L. Willcox

DVM, DACVIM (Oncology) University of California, Davis

Jennifer L. Willcox, DVM, DACVIM (Oncology), is an assistant professor of medical oncology at University of California, Davis. Her research interests include cancer-related imaging and novel therapeutics. Dr. Willcox received her veterinary degree from The Ohio State University, followed by a small animal rotating internship at a private practice in California and an oncology specialty internship at a private practice in Florida. She continued pursuing a specialty in oncology by completing a bone marrow transplant fellowship and a medical oncology residency at North Carolina State University. Before returning to the West Coast, Dr. Willcox held a 1-year clinical instructor position at University of Missouri.

Material from Clinician’s Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.

Up Next